Orion Corporation, Orion Pharma · 66-66 · FINLAND
For Orion Corporation, Orion Pharma · 66-66 · FINLAND, import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is FINLAND; product code is 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) | 62 I - - 30 Mercaptopurine (Anti-Neoplastic); date published is 09/30/2009; address is Orionintie 1 , Espoo, Helsinki-Uusimaa FINLAND, verified against its source on 2026-09-16.
- Firm
- Orion Corporation, Orion Pharma verified
- Import alert
- 66-66
- Import alert name
- "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"
- Country
- FINLAND verified
- Address
- Orionintie 1 , Espoo, Helsinki-Uusimaa FINLAND verified
- Date published
- 09/30/2009 verified
- Product code
- 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) | 62 I - - 30 Mercaptopurine (Anti-Neoplastic) each item verified
- FDA notes
- 11/2/2000 | 11/2/2000 each item verified
What the source says
Orion Corporation, Orion Pharma Date Published : 09/30/2009 Orionintie 1 , Espoo, Helsinki-Uusimaa FINLAND 61 U - - 05 Tamoxifen Citrate (Anti-Estrogen) Date Published: 09/30/2009 Notes: 11/2/2000 62 I - - 30 Mercaptopurine (Anti-Neoplastic) Date Published: 09/30/2009 Notes: 11/2/2000
— accessdata.fda.gov, retrieved 2026-09-15
The same source also states
Orion Corporation, Orion Pharma Date Published : 09/30/2009 Orionintie 1 , Espoo, Helsinki-Uusimaa FINLAND 66 M - - 09 Buspirone HCl (Tranquilizer) Date Published: 09/30/2009 Notes: 11/2/2000
— accessdata.fda.gov, retrieved 2026-09-15
Source
- accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html
This one changes, and we watch it.FDA import alert red lists: firms subject to detention without physical examination is re-read on a schedule and every change is dated. Subscribe: Atom feed · JSON · what has changed so far.